ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic inflammation extending to a variable extent from the rectum. These definitions of disease extent are recognised as somewhat arbitrary; in clinical practice, topically administered therapies are often used for UC whose extent is limited to the rectum and a portion of the sigmoid colon [proctosigmoiditis], with the term ‘distal colitis’ used to describe this disease distribution.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Care of the patient with UC requires appropriate input from across the multiprofessional team.
• 2 These guidelines summarise the recommended medical treatment for adults with UC.
• 3 Other ECCO guidelines consider the approach to UC diagnosis and monitoring, nursing care, management of disease complications, risk of infection, and technical aspects of surgery.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: